{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:22:22Z","timestamp":1791300142675,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP42551\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP42551\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["SERB-CRG\/2022\/007126"],"award-info":[{"award-number":["SERB-CRG\/2022\/007126"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR\/2021-10363"],"award-info":[{"award-number":["ICMR\/2021-10363"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2\/185\/Neuro\/NCD-1"],"award-info":[{"award-number":["3\/1\/2\/185\/Neuro\/NCD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SERB-CRG\/2018\/00349"],"award-info":[{"award-number":["SERB-CRG\/2018\/00349"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116959","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:52:21Z","timestamp":1729025541000},"page":"116959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of novel substituted (Z)-N\u2032-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer's disease"],"prefix":"10.1016","volume":"280","author":[{"given":"Gauri","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Praveen Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparajita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Ranjan","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritra","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanskriti","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.G.M.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8003-5566","authenticated-orcid":false,"given":"Gyan","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116959_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","article-title":"Design, synthesis, and evaluation of novel Ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"10","author":"Sang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116959_bib2","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/acs.jmedchem.7b01370","article-title":"Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer's disease","volume":"61","author":"Wu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib3","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1021\/acs.jmedchem.6b00151","article-title":"From companion diagnostics to theranostics: a new avenue for Alzheimer's disease?","volume":"59","author":"Bolognesi","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2024.116959_bib5","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-based search for new inhibitors of cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116959_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0009-2797(93)90042-W","article-title":"Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs","volume":"87","author":"Sussman","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.116959_bib7","series-title":"Genes, Environment and Alzheimer's Disease","first-page":"1","article-title":"Chapter 1 - molecular Mechanisms of Learning and Memory\u2217\u2217The authors declare no competing financial interests","author":"Puzzo","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116959_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","article-title":"Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present)","volume":"31","author":"Bortolami","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.116959_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116959_bib10","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3233\/JAD-160220","article-title":"Increased expression of readthrough acetylcholinesterase variants in the brains of Alzheimer's disease patients","volume":"53","author":"Campanari","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2024.116959_bib12","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.1c00534","article-title":"Selective pseudo-irreversible butyrylcholinesterase inhibitors transferring antioxidant moieties to the enzyme show pronounced neuroprotective efficacy in vitro and in vivo in an Alzheimer's disease mouse model","volume":"64","author":"Scheiner","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00002512-200118120-00001","article-title":"Selective inhibitors of butyrylcholinesterase","volume":"18","author":"Giacobini","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejmech.2024.116959_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2024.116959_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2024.116959_bib16","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1021\/acs.jmedchem.1c01619","article-title":"Near-infrared fluorescent probes as imaging and theranostic modalities for amyloid-beta and tau aggregates in alzheimer's disease","volume":"65","author":"Rai","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071544","article-title":"Insights into structure-activity relationships of 3-arylhydrazonoindolin-2-one derivatives for their multitarget activity on \u03b2-amyloid aggregation and neurotoxicity","volume":"23","author":"Purgatorio","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116959_bib18","doi-asserted-by":"crossref","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ejmech.2024.116959_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","article-title":"NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116959_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/acs.jmedchem.3c01782","article-title":"Design and discovery of novel NLRP3 inhibitors and PET imaging radiotracers based on a 1,2,3-triazole-bearing scaffold","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114468","article-title":"Development of sulfonamide-based NLRP3 inhibitors: further modifications and optimization through structure-activity relationship studies","volume":"238","author":"Xu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/alz.060356","article-title":"Development of NLRP3 inhibitors for intervening in Alzheimer's disease","volume":"18","author":"Xu","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2024.116959_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.2014.914168","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ejmech.2024.116959_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2024.116959_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116959_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s42004-019-0133-4","article-title":"Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model","volume":"2","author":"Dighe","year":"2019","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2231661","article-title":"Development of novel salicylic acid\u2013donepezil\u2013rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"38","author":"Zhou","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib29","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1021\/jm049782n","article-title":"Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues","volume":"47","author":"Bolognesi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.116959_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031084","article-title":"A review on recent approaches on molecular docking studies of novel compounds targeting acetylcholinesterase in alzheimer disease","volume":"28","author":"Peitzika","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116959_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/cr60216a003","article-title":"The chemistry of amidoximes and related compounds","volume":"62","author":"Eloy","year":"1962","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116959_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acschemneuro.1c00831","article-title":"Novel small-molecule inhibitor of NLRP3 inflammasome reverses cognitive impairment in an alzheimer's disease model","volume":"13","author":"Haseeb","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116959_bib34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0003-2697(78)90350-0","article-title":"Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations","volume":"86","author":"Gorun","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2024.116959_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112257","article-title":"Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease","volume":"198","author":"Singh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib36","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.jmedchem.0c01940","article-title":"Melatonin- and ferulic acid-based HDAC6 selective inhibitors exhibit pronounced immunomodulatory effects in vitro and neuroprotective effects in a pharmacological alzheimer's disease mouse model","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib37","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1021\/jm901902w","article-title":"Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives","volume":"53","author":"de Los R\u00edos","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.03.061","article-title":"Free radicals and polyphenols: the redox chemistry of neurodegenerative diseases","volume":"133","author":"Losada-Barreiro","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ejmech.2024.116959_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.ejmech.2024.116959_bib41","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/jm400970m","article-title":"Oxidative stress in Alzheimer's disease: are we connecting the dots?","volume":"57","author":"Rosini","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The role of antioxidants in the chemistry of oxidative stress: a review","volume":"97","author":"Pisoschi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235773","article-title":"Pharmacophore modeling and 3D-QSAR study of indole and isatin derivatives as antiamyloidogenic agents targeting Alzheimer's disease","volume":"25","author":"Purgatorio","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116959_bib44","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/jm3017317","article-title":"Progress and developments in tau aggregation inhibitors for Alzheimer disease","volume":"56","author":"Bulic","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4155\/ppa.14.22","article-title":"Advances in recent patent and clinical trial drug development for Alzheimer's disease","volume":"3","author":"Liu","year":"2014","journal-title":"Pharm Pat Anal"},{"key":"10.1016\/j.ejmech.2024.116959_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117047","article-title":"Guanidine-based \u03b2 amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): a review","volume":"74","author":"Gehlot","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib47","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1021\/acs.jmedchem.8b00610","article-title":"Tau-centric multitarget approach for alzheimer's disease: development of first-in-class dual glycogen synthase kinase 3\u03b2 and tau-aggregation inhibitors","volume":"61","author":"Gandini","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1567205011666141107150331","article-title":"Structure and mechanism of action of tau aggregation inhibitors","volume":"11","author":"Cisek","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2024.116959_bib49","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm901618d","volume":"53","author":"Ghosh","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","article-title":"Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease","volume":"48","author":"Robert","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116959_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2000.tb06938.x","article-title":"Metal chelation as a potential therapy for Alzheimer's disease","volume":"920","author":"Cuajungco","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2024.116959_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/016164104225016236","article-title":"Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias","volume":"26","author":"Togo","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejmech.2024.116959_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejmech.2024.116959_bib54","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1038\/s41598-022-13002-w","article-title":"Nanofibrous materials affect the reaction of cytotoxicity assays","volume":"12","author":"Podg\u00f3rski","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116959_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib56","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of alzheimer's disease","volume":"52","author":"Arce","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116385","article-title":"Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease","volume":"46","author":"Singh","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","article-title":"Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for Alzheimer's disease","volume":"168","author":"Chalupova","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib59","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116959_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116959_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acschemneuro.0c00642","article-title":"Characterization of homogeneous and heterogeneous amyloid-\u03b242 oligomer preparations with biochemical methods and infrared spectroscopy reveals a correlation between infrared spectrum and oligomer size","volume":"12","author":"Vosough","year":"2021","journal-title":"ACS Chem. Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:09Z","timestamp":1777529289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":61,"alternative-id":["S0223523424008407"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116959","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel substituted (Z)-N\u2032-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116959"}}